M E Conolly, J K Greenacre J Clin Invest. 1976;58(6):1307-1316. https://doi.org/10.1172/JCI108586. beta-Adrenoceptor function has been compared in lymphocytes of normal subjects, asthmatic patients taking large doses of beta-adrenergic bronchodilators, and comparable asthmatics treated exclusively with nonadrenergic medication. The effect of prolonged administration of beta-adrenoceptor agonists on receptor function in normal subjects has also been examined. beta-receptor response in each situation was quantitated by changes in levels of cyclic AMP, measured by a protein-binding assay. Dose response curves to isoproterenol (10 nM-0.1 mM) have been constructed for each group. Maximal increase in cyclic AMP in lymphocytes from normal subjects (393.2+/-44.0%) and in asthmatics on nonadrenergic preparations (408.3+/-46.7%) was significantly greater (P less than 0.001) than in asthmatics taking large doses of beta-sympathomimetics (67.5+/-24.2%). Depression of the cyclic AMP response appeared to correlate with the degree of exposure to beta-adrenergic agonists but not with the prevailing severity of the patient's asthma. Withdrawal of beta-adrenergic drugs was followed by a reversion of the cyclic AMP response to normal values, which suggests that the depression was drug-induced rather than an inherent feature of the disease. This interpretation was confirmed by the finding that prolonged exposure of normal subjects to high doses of a beta-adrenergic agonist caused a marked and significant (p less than 0.001) reduction in the cyclic AMP response, very similar to that seen in asthmatics on large doses of adrenergic bronchodilators. A B S T R A C T 83-adrenoceptor function has been compared in lymphocytes of normal subjects, asthmatic patients taking large doses of f3-adrenergic bronchodilators, and comparable asthmatics treated exclusively with nonadrenergic medication. The effect of prolonged administration of 8-adrenoceptor agonists on receptor function in normal subjects has also been examined. ,8-receptor response in each situation was quantitated by changes in levels of cyclic AMP, measured by a protein-binding assay.
A B S T R A C T 83-adrenoceptor function has been compared in lymphocytes of normal subjects, asthmatic patients taking large doses of f3-adrenergic bronchodilators, and comparable asthmatics treated exclusively with nonadrenergic medication. The effect of prolonged administration of 8-adrenoceptor agonists on receptor function in normal subjects has also been examined. ,8-receptor response in each situation was quantitated by changes in levels of cyclic AMP, measured by a protein-binding assay.
Dose response curves to isoproterenol (10 nM-0.1 mM) have been constructed for each group. Maximal increase in cyclic AMP in lymphocytes from normal subjects (393.2+44.0%) and in asthmatics on nonadrenergic preparations (408.3±46.7%) was significantly greater (P<0.001) than in asthmatics taking large doses of,8f-sympathomimetics (67.5±24.2%).
Depression of the cyclic AMP response appeared to correlate with the degree of exposure to 13-adrenergic agonists but not with the prevailing severity of the patient's asthma.
Withdrawal of 13-adrenergic drugs was followed by a reversion of the cyclic AMP response to normal values, which suggests that the depression was drug-induced rather than an inherent feature of the disease.
This interpretation was confirmed by the finding that prolonged exposure of normal subjects to high doses of a,13-adrenergic agonist caused a marked and significant (P < 0.001) reduction in the cyclic AMP response, very similar to that seen in asthmatics on large doses of adrenergic bronchodilators.
A possible link between drug-induced changes in the cyclic AMP response and the rise in the United Kingdom asthma death rate in the 1960's is discussed.
INTRODUCTION
Adrenergic activity is a key part of the physiological and pharmacological response to bronchial asthma. Bronchial smooth muscle relaxation results directly from 13-adrenoceptor stimulation, but the same receptor mechanism is also important in inhibiting the release of histamine, as shown by Schild (1), slowreacting substance of anaphylaxis, reported by Orange et al. (2) , and prostaglandins (Liebig, et al. [3] ), presumably from mast cells in the lung parenchyma. For this reason, factors that impair this mechanism (for example injudicious use of nonselective p-blocking drugs) can have serious consequences in asthmatic patients. The hypothesis advanced by Szentivanyi (4, 5) , that an inherent defect of the 18-adrenoceptor was a major etiological factor in atopic diseases such as asthma, has therefore attracted considerable attention and provoked a great deal of research.
There are obvious difficulties that hinder direct investigation of cellular mechanisms in human lung. An ingenious solution to this problem, first suggested by Smith and Parker (6) , has been to use peripheral blood leukocytes, which themselves possess ,8-adrenoceptors. This approach presupposes a pharmacological identity between the lung and leukocyte receptors. We have recently confirmed that both have the characteristics of a 12 receptor.1 It is also necessary to assume that changes affecting the leukocyte ,3-receptors will affect those of mast cells in lung tissue. This is less certain, though the suggestion of Bumet (7, 8) , that mast cells and basophils may be postmitotic derivatives of thymus-derived lymphocytes, gives some support to 1 Cyclic AMP purification and assay. The cells were homogenized with a teflon pestle and centrifuged, and the supernatant was applied to a 2.0 x 0.5-cm column of Dowex resin (AG 1 x 8 formate form, 200-400 mesh, Bio-Rad Laboratories, Richmond, Calif.). The columns were washed with water, and then the cyclic AMP was eluted with 12 ml 2 N formic acid, which did not elute cyclic 3'5' GMP from the columns. The eluate was lvophilized, the residue dissolved in 1 ml phosphate buffer, pH 6.5, and cyclic AMP assayed.
A obtained by comparing results in some samples before and subjects, and therefore also differed significantly after incubation with beefheart phosphodiesterase (Boehringer (p < 0.001) from the other group of patients. These
Mannheim, London, England).
results are summarized in Fig. 1 . Full dose-response curves ofthe different groups were compared by two-way analysis of variance with replication (20) .
If the data are expressed in terms of absolute levels of cyclic AMP rather than as percentage RESULTS increases, the average response for asthmatics on nonadrenergic drugs is somewhat lower than the mean There is a highly significant difference (P < 0.001) for normal subjects (P < 0.001). However, as shown in the response of lymphocytes from normal subjects in Tables III and V, all these values fall within the and asthmatics on large doses of adrenergic drugs. In range spanned by normal subjects, and the difference contrast, the response of asthmatics on nonadrenergic between the two groups of asthmatics (Tables IV and  drugs was almost identical to that seen in normal V) remains significant (P < 0.001).
,-Adrenoceptor Function in Bronchial Asthma: Effects of Drug Therapy 1311 The study of obstetric patients before and after a 48-h infusion of isoxsuprine indicate quite clearly that the cyclic AMP response can be markedly depressed in normal subjects after prolonged exposure to 18-adrenergic agonists. The control dose response curve was virtually identical to that seen in the normal subjects shown in Fig. 1 . After the infusion, the 100.0 FIGURE 3 Percent increase in cyclic AMP in lymphocytes taken from patient 2, a 63-yr-old woman, presenting with severe asthma, and taking large doses of /-adrenergic bronchodilators (O ---0). The patient was restudied 30 days later when she had been changed over to nonadrenergic therapy (A ---A). Dose-response curve for 11 normal subjects is given for comparison (-0). Incubation conditions in each study as described for Fig. 1 30 (v---*) during changeover to nonadrenergic therapy. Dose-response curve for 11 normal subjects given for comparison (v-0). Incubation conditions in each study were as described for Fig. 1 . PEFR, peak expiratory flow rate (liters/minute).
response was significantly reduced (P < 0.001), approaching that seen in patients taking large doses of ,/-adrenergic bronchodilators. These results are summarized in Fig. 5 .
DISCUSSION
These studies show a significant difference between the percent increase in the cyclic AMP response in lymphocytes from asthmatic patients taking excessive doses of adrenergic drugs on one hand, and that from normal subjects or from asthmatics taking only nonadrenergic drugs on the other.4 Other studies 4Although, as pointed out above, the absolute levels of cyclic AMP in lymphocytes from normal subjects was on average higher than the absolute levels in lymphocytes from asthmatics on nonadrenergic medication, the range that this group of patients covered did not fall outside the range of normal values. It seems unlikely, therefore, in view of the close similarity in the percent increase in cyclic AMP in these two groups ofsubjects, that this difference has any biological significance. CL stantial contribution to the changes reported here, although a limited contribution cannot be excluded. The use of the lymphocyte as a model for studying bronchial asthma requires critical examination. Its constant accessibility regardless of the patients' condition permits clinical studies that would otherwise be impossible. The postulated relationship to mast cells mentioned above lends further justification to its use. However, its limitations must be recognized. Firstly, there is considerable variability both within and between subjects. Other workers have also observed this, and Smith and Parker (6) have suggested that this might be due to variations in thymus (T)-and bone marrow-derived (B) lymphocytes in the samples studied. In other mammals, considerable differences in the response to catecholamines have been noted in the various subsets of the lymphocyte population (38) . It is known that separation of lymphocytes by density gradient centrifugation may lead to variable and unpredictable losses of T lymphocytes.5 This may explain some of the variability that we observed. To a large extent the problem can be overcome by analyzing the data as proportional increases, since cell population with low basal levels of cyclic AMP reach low maxima and vice versa. Nevertheless, the variability encountered robs the method of precision. Secondly, even when it might be expected, there is not a good correlation between respiratory function tests and lymphocyte performance. Clearly, in a multifactorial disease like asthma, perfect correlation will not be obtained, but it also has to be recognized that even in tissues which all possess receptors currently classified as 32 in type, the susceptibility to desensitization appears to vary (39, 40) , and in this respect bronchial smooth muscle and lymphocytes clearly do not correlate well.
The importance of drug-induced adrenergic desensitization in severe asthma remains uncertain.
However, the adverse effects of,8(-blocking drugs, such as propranolol, in some asthmatics are well known, and it is conceivable that drug-induced desensitization could create an analogous situation in asthmatics abusing adrenergic bronchodilators. It is possible that this could have contributed to the rise in asthma mortality linked to the excessive use of aerosols of such preparations (41, 42) . The lymphocyte may provide a useful tool for studying cellular mechanisms in man, and in the evaluation of various pharmacologic interventions. Viewed in this way it has a place in the study of bronchial asthma, although its limitations restrict its usefulness in studying single individuals.
5Thompson, A., and S. Vaughan-Smith. 1975 . Personal communication.
